Year |
Citation |
Score |
2010 |
Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. The American Journal of Pathology. 176: 2029-38. PMID 20133814 DOI: 10.2353/Ajpath.2010.090755 |
0.647 |
|
2010 |
Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 115: 887-95. PMID 19965636 DOI: 10.1182/Blood-2009-08-236745 |
0.653 |
|
2009 |
Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Research. 69: 3736-45. PMID 19366806 DOI: 10.1158/0008-5472.Can-08-3232 |
0.623 |
|
2009 |
Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 113: 254-63. PMID 18836096 DOI: 10.1182/Blood-2008-02-140020 |
0.648 |
|
2008 |
Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood. 112: 1720-9. PMID 18559979 DOI: 10.1182/Blood-2007-09-112748 |
0.625 |
|
2007 |
Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. British Journal of Cancer. 96: 1083-91. PMID 17353927 DOI: 10.1038/Sj.Bjc.6603642 |
0.588 |
|
2007 |
Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 109: 4753-60. PMID 17311993 DOI: 10.1182/Blood-2006-12-063933 |
0.66 |
|
2006 |
Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. The American Journal of Pathology. 169: 279-93. PMID 16816380 DOI: 10.2353/Ajpath.2006.050889 |
0.621 |
|
Show low-probability matches. |